Free Trial
NASDAQ:GNFT

GENFIT (GNFT) Stock Price, News & Analysis

GENFIT logo
$3.87 -0.19 (-4.68%)
As of 08/29/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About GENFIT Stock (NASDAQ:GNFT)

Key Stats

Today's Range
$4.00
$4.13
50-Day Range
$3.61
$4.50
52-Week Range
$2.55
$6.42
Volume
1,234 shs
Average Volume
3,790 shs
Market Capitalization
$194.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Buy

Company Overview

GENFIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

GNFT MarketRank™: 

GENFIT scored higher than 38% of companies evaluated by MarketBeat, and ranked 720th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GENFIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GENFIT has only been the subject of 1 research reports in the past 90 days.

  • Read more about GENFIT's stock forecast and price target.
  • Earnings Growth

    Earnings for GENFIT are expected to decrease in the coming year, from $0.95 to ($0.57) per share.

  • Price to Book Value per Share Ratio

    GENFIT has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about GENFIT's valuation and earnings.
  • Percentage of Shares Shorted

    0.07% of the float of GENFIT has been sold short.
  • Short Interest Ratio / Days to Cover

    GENFIT has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in GENFIT has recently decreased by 2.30%, indicating that investor sentiment is improving.
  • Dividend Yield

    GENFIT does not currently pay a dividend.

  • Dividend Growth

    GENFIT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the float of GENFIT has been sold short.
  • Short Interest Ratio / Days to Cover

    GENFIT has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in GENFIT has recently decreased by 2.30%, indicating that investor sentiment is improving.
  • News Sentiment

    GENFIT has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for GENFIT this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for GNFT on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GENFIT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.20% of the stock of GENFIT is held by insiders.

  • Percentage Held by Institutions

    Only 2.24% of the stock of GENFIT is held by institutions.

  • Read more about GENFIT's insider trading history.
Receive GNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNFT Stock News Headlines

FY2025 Earnings Estimate for GENFIT Issued By HC Wainwright
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.tc pixel
HC Wainwright Initiates Coverage on GENFIT (NASDAQ:GNFT)
See More Headlines

GNFT Stock Analysis - Frequently Asked Questions

GENFIT's stock was trading at $3.71 at the beginning of 2025. Since then, GNFT stock has increased by 4.9% and is now trading at $3.8910.

GENFIT (GNFT) raised $132 million in an initial public offering on Wednesday, March 27th 2019. The company issued 5,000,000 shares at a price of $26.33 per share. SVB Leerink and Barclays served as the underwriters for the IPO and Bryan, Garnier, Natixis, Roth Capital Partners and H.C. Wainwright & Co. were co-managers.

Shares of GNFT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GENFIT investors own include Intercept Pharmaceuticals (ICPT), InterDigital (IDCC), NVIDIA (NVDA), Occidental Petroleum (OXY), Vaxart (VXRT), American Airlines Group (AAL) and Carnival (CCL).

Company Calendar

Today
8/29/2025
Next Earnings (Estimated)
9/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNFT
CIK
1757064
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$9.00
Potential Upside/Downside
+131.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
1.23
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$76.77 million
Price / Sales
2.53
Cash Flow
$0.07 per share
Price / Cash Flow
58.07
Book Value
$1.50 per share
Price / Book
2.59

Miscellaneous

Outstanding Shares
50,000,000
Free Float
47,903,000
Market Cap
$194.55 million
Optionable
Not Optionable
Beta
1.14

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:GNFT) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners